Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Tirzepatide (Mounjaro, Zepbound): A Dual GLP-1/GIP Receptor Agonist for Weight Loss and Diabetes Control In May 2022, tirzepatide was approved for diabetes management under the name Mounjaro, and the FDA expanded this approval to weight loss under the brand name Zepbound in November 2023 (owned by the pharmaceutical company Lilly)
Luxura Med Spa is at the forefront of innovation in the realm of weight loss
Then verify it yourself with a calculator
Notably, administration of GEP44 resulted in an 80% reduction in food intake and a more profound loss of body weight than what could be achieved in response to treatment with several of the US Food and Drug Administration (FDA)-approved GLP-1RAs, including Ex-4 and liraglutide (LIRA)
If a patient receives a GLP-1 medication by mail-order pharmacy, they should refrigerate it immediately upon arrival
Soft-sided coolers with ice packs
